Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V De Ledinghen

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Viral Hepatitis|June 24, 2006
Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis CL Castera, A Constant, P-H Bernard, et al.
Lancet (London, England)|August 27, 1994
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacinT Barrioz, P Ingrand, I Besson, et al.
Alimentary Pharmacology & Therapeutics|February 7, 2017
Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?P Calès, J Boursier, J Lebigot, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis CL Castera, A Constant, C Henry, et al.
Gastroenterologie Clinique Et Biologique|August 30, 2000
[Vascular pathology of the portal vein distal branches: a rare cause of liver transplantation and a protean clinical presentation]J F Blanc, P H Bernard, B Le Bail, et al.
Investigative Radiology|March 20, 1999
Segmented 5 versus nonsegmented flow quantitation: comparison of portal vein flow measurementsE Laffon, R Lecesne, V De Ledinghen, et al.
Presse Medicale (Paris, France : 1983)|April 20, 2001
[Cyclooxygenase inhibitors]P Eschwège, V de Ledinghen, T Camilli, et al.
Presse Medicale (Paris, France : 1983)|April 20, 2001
[Arachidonic acid and prostaglandins, inflammation and oncology]P Eschwège, V de Ledinghen, T Camilli, et al.
Presse Medicale (Paris, France : 1983)|April 20, 2001
[Cyclooxygenases]P Eschwège, V de Ledinghen, T Camilli, et al.
Hepatology (Baltimore, Md.)|February 14, 1998
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infectionM J Moran, A Fontanellas, E Brudieux, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Viral Hepatitis|June 24, 2006
Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis CL Castera, A Constant, P-H Bernard, et al.
Lancet (London, England)|August 27, 1994
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacinT Barrioz, P Ingrand, I Besson, et al.
Alimentary Pharmacology & Therapeutics|February 7, 2017
Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?P Calès, J Boursier, J Lebigot, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis CL Castera, A Constant, C Henry, et al.
Gastroenterologie Clinique Et Biologique|August 30, 2000
[Vascular pathology of the portal vein distal branches: a rare cause of liver transplantation and a protean clinical presentation]J F Blanc, P H Bernard, B Le Bail, et al.
Investigative Radiology|March 20, 1999
Segmented 5 versus nonsegmented flow quantitation: comparison of portal vein flow measurementsE Laffon, R Lecesne, V De Ledinghen, et al.
Presse Medicale (Paris, France : 1983)|April 20, 2001
[Cyclooxygenase inhibitors]P Eschwège, V de Ledinghen, T Camilli, et al.
Presse Medicale (Paris, France : 1983)|April 20, 2001
[Arachidonic acid and prostaglandins, inflammation and oncology]P Eschwège, V de Ledinghen, T Camilli, et al.
Presse Medicale (Paris, France : 1983)|April 20, 2001
[Cyclooxygenases]P Eschwège, V de Ledinghen, T Camilli, et al.
Hepatology (Baltimore, Md.)|February 14, 1998
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infectionM J Moran, A Fontanellas, E Brudieux, et al.
Pageof 3